Intravitreal Injections by Nurses and Physicians Compared
Primary Purpose
Eye Diseases
Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
intravitreal injections given by a nurse
intravitreal injections given by a physician
Intravitreal injections
Anti-VEGF agents
Sponsored by
About this trial
This is an interventional supportive care trial for Eye Diseases focused on measuring Intravitreal injections, Nurses, Physicians
Eligibility Criteria
Inclusion Criteria:
- referred to the eye clinic for treatment of age related macular degeneration, diabetes retinopathy or retinal vein occlusion with anti-vascular endothelium growth factor
- Ability to provide written informed consent
- ability to comply with study assessments for the full duration of the study
Exclusion Criteria:
-
Sites / Locations
- St Olavs Hospital, Department of Ophthalmology
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
nurse
physician
Arm Description
intravitreal injections with anti-VEGF agents given by a nurse
intravitreal injections with anti-VEGF agents given by a physician
Outcomes
Primary Outcome Measures
change in visual acuity
Mean change in visual acuity from baseline to 12 months, tested on ETDRS letter chart
Secondary Outcome Measures
incidence of ocular adverse events
patient satisfaction
questionnaire after the first treatment will be compared with questionnaire after 12 months
Full Information
NCT ID
NCT02359149
First Posted
February 4, 2015
Last Updated
July 4, 2019
Sponsor
St. Olavs Hospital
Collaborators
Norwegian University of Science and Technology
1. Study Identification
Unique Protocol Identification Number
NCT02359149
Brief Title
Intravitreal Injections by Nurses and Physicians Compared
Official Title
Intravitreal Injections by Nurses or Physicians: a Randomized Controlled Trial Comparing Efficacy, Patient Satisfaction and Health Economy
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
March 2015 (Actual)
Primary Completion Date
March 31, 2017 (Actual)
Study Completion Date
March 31, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
St. Olavs Hospital
Collaborators
Norwegian University of Science and Technology
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Anti-VEGF agents are given for a variety of previously untreatable eye diseases. The last years indications for their use and consequently the number of patients needing treatment, have been increasing. Most patients require multiple injections. This has resulted in many eye departments administering thousands of injections per year, also at St Olavs University Hospital Trondheim. To cope with this increase in workload, it would be helpful if injections would be given not only by the physicians but also by the nurses. This study's objective is to compare efficiency, patient satisfaction and cost per patient of injections given by nurses and physicians.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Eye Diseases
Keywords
Intravitreal injections, Nurses, Physicians
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
328 (Actual)
8. Arms, Groups, and Interventions
Arm Title
nurse
Arm Type
Experimental
Arm Description
intravitreal injections with anti-VEGF agents given by a nurse
Arm Title
physician
Arm Type
Active Comparator
Arm Description
intravitreal injections with anti-VEGF agents given by a physician
Intervention Type
Procedure
Intervention Name(s)
intravitreal injections given by a nurse
Intervention Type
Procedure
Intervention Name(s)
intravitreal injections given by a physician
Intervention Type
Procedure
Intervention Name(s)
Intravitreal injections
Intervention Type
Drug
Intervention Name(s)
Anti-VEGF agents
Other Intervention Name(s)
anti vasculer endothelial growth factor
Primary Outcome Measure Information:
Title
change in visual acuity
Description
Mean change in visual acuity from baseline to 12 months, tested on ETDRS letter chart
Time Frame
1 year
Secondary Outcome Measure Information:
Title
incidence of ocular adverse events
Time Frame
from baseline to 12 months
Title
patient satisfaction
Description
questionnaire after the first treatment will be compared with questionnaire after 12 months
Time Frame
12 months
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
referred to the eye clinic for treatment of age related macular degeneration, diabetes retinopathy or retinal vein occlusion with anti-vascular endothelium growth factor
Ability to provide written informed consent
ability to comply with study assessments for the full duration of the study
Exclusion Criteria:
-
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marit Fagerli, md
Organizational Affiliation
St Olavs University Hospital
Official's Role
Study Director
Facility Information:
Facility Name
St Olavs Hospital, Department of Ophthalmology
City
Trondheim
Country
Norway
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
27716253
Citation
Austeng D, Morken TS, Bolme S, Follestad T, Halsteinli V. Nurse-administered intravitreal injections of anti-VEGF: study protocol for noninferiority randomized controlled trial of safety, cost and patient satisfaction. BMC Ophthalmol. 2016 Oct 1;16(1):169. doi: 10.1186/s12886-016-0348-4.
Results Reference
background
PubMed Identifier
31267688
Citation
Bolme S, Morken TS, Follestad T, Sorensen TL, Austeng D. Task shifting of intraocular injections from physicians to nurses: a randomized single-masked noninferiority study. Acta Ophthalmol. 2020 Mar;98(2):139-144. doi: 10.1111/aos.14184. Epub 2019 Jul 3.
Results Reference
result
Learn more about this trial
Intravitreal Injections by Nurses and Physicians Compared
We'll reach out to this number within 24 hrs